Michel D
Fortschr Med. 1991 Aug 30;109(25):496-9.
In the treatment of heart failure-also in the aged-digitalis preparations remain indispensable. At the present time, in particular in combination with diuretics and ACE inhibitors, they are experiencing a revival in the treatment of severe stages (NYHA stages III and IV). In addition, a spectrum of newly developed positive inotropic substances of various classes is now available. Among the catecholamines, apart from dopamine, dobutamine and their derivatives, new drugs with a beta-adrenergic agonistic effect are presently undergoing clinical testing. Another heterogeneous group of substances combine positive inotropic with vasodilatory properties. In this connection, mention might be made of the phosphodiesterase inhibitors, the H2 receptor antagonists, and certain catecholamine derivatives. However, digitalis remains the only substance that can be given orally over the long-term without tolerance developing. Particular aspects of the use of digitalis in geriatric patients are discussed.
在心力衰竭的治疗中——包括老年患者——洋地黄制剂仍然不可或缺。目前,特别是与利尿剂和血管紧张素转换酶抑制剂联合使用时,它们在重度阶段(纽约心脏协会III级和IV级)的治疗中正在复兴。此外,现在有一系列新开发的各类正性肌力药物。在儿茶酚胺类药物中,除了多巴胺、多巴酚丁胺及其衍生物外,具有β-肾上腺素能激动作用的新药目前正在进行临床试验。另一类性质各异的物质兼具正性肌力和血管舒张特性。在此方面,可以提及磷酸二酯酶抑制剂、H2受体拮抗剂以及某些儿茶酚胺衍生物。然而,洋地黄仍然是唯一一种可以长期口服且不会产生耐受性的药物。本文讨论了洋地黄在老年患者中使用的特殊方面。